Company intelligence / Profile preview

Zenara Pharma

Hyderabad, Telangana, India

Ownership: Private
Development stage: Other

Overview

Zenara Pharma is a vertically integrated pharmaceutical company specializing in R&D and manufacturing of affordable generic and complex finished dosage forms, with US FDA and global regulatory approvals. Notable programs include exclusive US launch of generic sertraline hydrochloride capsules (first FDA-approved generic with 180-day exclusivity) and commercial launches of nirmatrelvir + ritonavir ('Paxzen') for COVID-19 and favipiravir ('Favizen') for viral infections. The company maintains robust commercial and approval track records, particularly for central nervous system and anti-infective drugs.

Therapeutic areas: Infectious DiseasesPsychiatry
Modalities: Small molecule
Industry: Biotech

Partnerships

Pfizer (Paxlovid generic collaboration/sponsorship)ANI Pharmaceuticals (indirect, via Biophore for ANDA products)

Beyond the preview

Go deeper on Zenara Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zenara Pharma.

Explore the full profile